Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Insulin titration protocol in hospitalized type 2 diabetes
NCT01407289Phase 4Completed
- Sponsor
- Medical University of Graz
- Start
- Jun 2011
- Primary completion
- Apr 2012
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label trial of insulin aspart and insulin glargine in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by Medical University of Graz. Primary endpoint: Mean blood glucose. Started Jun 2011; status: completed.
02
Drugs
insulin aspartinsulin glargine
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01407289.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01407289.